Screening for antifibrotic compounds using high throughput system based on fluorescence polarization
Screening for antifibrotic compounds using high throughput system based on fluorescence polarization
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Fibroproliferative diseases are one of the leading causes of death worldwide. They are characterized by reactive fibrosis caused by uncontrolled synthesis of type I collagen. There is no cure for fibrosis and development of therapeutics that can inhibit collagen synthesis is urgently needed. Collagen α1(I) mRNA and α2(I) mRNA encode for type I coll...
Alternative Titles
Full title
Screening for antifibrotic compounds using high throughput system based on fluorescence polarization
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0713f252973342099dd38d423740ba72
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0713f252973342099dd38d423740ba72
Other Identifiers
ISSN
2079-7737
E-ISSN
2079-7737
DOI
10.3390/biology3020281
